Solid forms of a triazine derivative as cbl-b modulator
AssigneeHotspot Therapeutics, Inc.
InventorsJon P. LAWSON, Ken CARSON, Yingzhi BI
Life of this patent
Estimating the term…
Abstract
The present disclosure provides, in part, provides crystalline forms of the compound of formula (I). Also provided are pharmaceutical compositions including a crystalline form of the compound of formula (I), as well as methods of treating various condition, diseases, and disorders using the crystalline forms of the compound of formula (I) and pharmaceutical compositions.
Claims76
A crystalline form of a compound of formula (I):
A crystalline form of a compound of formula (I):
- wherein the crystalline form is characterized by an X-ray powder diffraction (XRPD) pattern comprising one or more peaks selected from 6.0°±0.2°, 8.6°±0.2°, 14.3°±0.2°, and 16.3°±0.2°2-theta.
A crystalline solvate of a compound of formula (I):
A crystalline acetone solvate of a compound of formula (I):
A crystalline p-dioxane solvate of a compound of formula (I):
A crystalline tetrahydrofuran solvate of a compound of formula (I):
A crystalline citrate salt of a compound of formula (I):
Dependencies are inferred from the claim text.